-
Early Health Technology Assessment and Cost-Effectiveness of the National Cardiovascular Disease Prevention Program in Greece
Sep 9, 2025, 16:22 PM -
When Cost-Effectiveness No Longer Counts: Industry Views on the Undermining of HTA Principles in Korea
Sep 9, 2025, 16:22 PM -
Predicting PICOs Through Machine-Learning–Powered Information Compression and Statistical Ranking
Sep 9, 2025, 16:22 PM -
Cost Analysis of the Extravascular Implantable Cardioverter-Defibrillator Compared to the Subcutaneous System in Patients at Risk of Sudden Cardiac Death in Italy
Sep 9, 2025, 16:22 PM -
Persistence With Antidementia Therapy in Germany: A Retrospective Cohort Study of 212,850 Patients
Sep 9, 2025, 16:22 PM -
Global Adoption of Dynamic Transmission Models in Infectious Disease Vaccine Submissions: A Comparative Analysis Across the EU5 North America and Scandinavia
Sep 9, 2025, 16:22 PM -
Implementing Simultaneous Maximum Acceptable Risk Thresholds (SMARTs) in Discrete Choice Experiments (DCE): A Feasible Approach to Quantify Tolerance for Multiple Risks
Sep 9, 2025, 16:22 PM -
Hybrid Digital Support for Patients Receiving Biosimilar-Adalimumab Therapy for Immune-Mediated Inflammatory Disorders: 12-Month Persistence and Impact on Adherence
Sep 9, 2025, 16:22 PM -
Global Access Licensing: An Expert Interview Study with Scientists-Inventors and Directors of Technology Transfer Offices Involved in the Development and Commercialization of COVID-19 Vaccines
Sep 9, 2025, 16:22 PM -
The Impact of Inflation: A Cost Analysis in the Spanish Pharmaceutical Sector From 2014 to 2023
Sep 9, 2025, 16:22 PM -
A Review of NICE Technology Appraisals in Oncology Including Economic Evaluations With Time-Varying Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
The Road Ahead: A Qualitative Study Mapping the Experience of Patients With Chronic Kidney Disease
Sep 9, 2025, 16:22 PM -
Machine Learning for Missing Data Imputation in Healthcare Research: A Systematic Review of Methods and Applications
Sep 9, 2025, 16:22 PM -
Psychotropic Medications to Patients With Treatment-Resistant Depression in France
Sep 9, 2025, 16:22 PM -
Reassessment of Orphan Drugs in Germany After Exceeding the Annual Sales Limit of €30 Million: Impact on the Reimbursement Price and Key Influencing Factors
Sep 9, 2025, 16:22 PM -
Identifying Patient-Reported Outcome Measures to Capture Patients’ Experiences of Symptoms and Impacts of Acute Myeloid Leukemia (AML)
Sep 9, 2025, 16:22 PM -
Advancing Multiple System Atrophy Diagnosis: Combining AI and Decision Analysis
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Time Burden in Patients With Myelodysplastic Syndromes/Neoplasms Initiating Oral Decitabine and Cedazuridine or Intravenous/Subcutaneous Hypomethylating Agents
Sep 9, 2025, 16:22 PM -
Harmonization of Drug Policy and Regulation Across Europe: A Comparison Between the European Medicines Agency and the European HTA Regulation
Sep 9, 2025, 16:22 PM -
Are We Measuring What Matters in Postpartum Depression Trials?
Sep 9, 2025, 16:22 PM
